Literature DB >> 34424048

Recent Emergence of Aztreonam-Avibactam Resistance in NDM and OXA-48 Carbapenemase-Producing Escherichia coli in Germany.

Patrice Nordmann1,2,3, Yancheng Yao4,5, Linda Falgenhauer5,6, Mustafa Sadek1,7, Can Imirzalioglu4,5, Trinad Chakraborty4,5.   

Abstract

Entities:  

Keywords:  CMY; IncIγ; NDM; OXA; aztreonam-avibactam; chimeric plasmid; penicillin-binding protein 3; transfer

Mesh：

Substances：

Year:  2021        PMID： 34424048      PMCID： PMC8522741          DOI： 10.1128/AAC.01090-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  The genome sequence of the incompatibility group Iγ plasmid R621a: evolution of IncI plasmids.

Authors:  Hiroyuki Takahashi; Ming Shao; Nobuhisa Furuya; Teruya Komano
Journal:  Plasmid       Date:  2011-07-08       Impact factor: 3.466

Review 2.  Spread and Persistence of Virulence and Antibiotic Resistance Genes: A Ride on the F Plasmid Conjugation Module.

Authors:  Günther Koraimann
Journal:  EcoSal Plus       Date:  2018-07

Review 3.  The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.

Authors:  Amy J Mathers; Gisele Peirano; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Genetic Features Leading to Reduced Susceptibility to Aztreonam-Avibactam among Metallo-β-Lactamase-Producing Escherichia coli Isolates.

Authors:  Mustafa Sadek; Mario Juhas; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

5.  Human carriage of cefotaxime-resistant Escherichia coli in North-East India: an analysis of STs and associated resistance mechanisms.

Authors:  Deepjyoti Paul; Dmitriy Babenko; Mark A Toleman
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

6.  Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics.

Authors:  Florian Lorme; Naouale Maataoui; Emilie Rondinaud; Marina Esposito-Farèse; Olivier Clermont; Etienne Ruppe; Guillaume Arlet; Nathalie Genel; Sophie Matheron; Antoine Andremont; Laurence Armand-Lefevre
Journal:  PLoS One       Date:  2018-12-18       Impact factor: 3.240

Review 7.  β-Lactamases and β-Lactamase Inhibitors in the 21st Century.

Authors:  Catherine L Tooke; Philip Hinchliffe; Eilis C Bragginton; Charlotte K Colenso; Viivi H A Hirvonen; Yuiko Takebayashi; James Spencer
Journal:  J Mol Biol       Date:  2019-04-05       Impact factor: 5.469

8.  Complete Nucleotide Sequence of Plasmids of Two Escherichia coli Strains Carrying bla NDM- 5 and bla NDM - 5 and bla OXA - 181 From the Same Patient.

Authors:  Vittoria Mattioni Marchetti; Ibrahim Bitar; Alessandra Mercato; Elisabetta Nucleo; Annalisa Bonomini; Palmino Pedroni; Jaroslav Hrabak; Roberta Migliavacca
Journal:  Front Microbiol       Date:  2020-01-21       Impact factor: 5.640

9.  Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study.

Authors:  Oliver A Cornely; José M Cisneros; Julian Torre-Cisneros; María Jesús Rodríguez-Hernández; Luis Tallón-Aguilar; Esther Calbo; Juan P Horcajada; Christian Queckenberg; Ulrike Zettelmeyer; Dorothee Arenz; Clara M Rosso-Fernández; Silvia Jiménez-Jorge; Guy Turner; Susan Raber; Seamus O'Brien; Alison Luckey
Journal:  J Antimicrob Chemother       Date:  2020-03-01       Impact factor: 5.790
View more
  5 in total

Review 1.  OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.

Authors:  Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2022-07-20       Impact factor: 5.938

Review 2.  The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations.

Authors:  Abdullah Tarık Aslan; Murat Akova
Journal:  Antibiotics (Basel)       Date:  2022-02-20

Review 3.  Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens.

Authors:  Flora Cruz-López; Adrian Martínez-Meléndez; Rayo Morfin-Otero; Eduardo Rodriguez-Noriega; Héctor J Maldonado-Garza; Elvira Garza-González
Journal:  Front Cell Infect Microbiol       Date:  2022-05-20       Impact factor: 6.073

4.  New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria.

Authors:  Yancheng Yao; Can Imirzalioglu; Linda Falgenhauer; Trinad Chakraborty
Journal:  Emerg Infect Dis       Date:  2022-01       Impact factor: 6.883

5.  Extensively Drug-Resistant Klebsiella pneumoniae Counteracts Fitness and Virulence Costs That Accompanied Ceftazidime-Avibactam Resistance Acquisition.

Authors:  Elias Eger; Michael Schwabe; Lukas Schulig; Nils-Olaf Hübner; Jürgen A Bohnert; Uwe T Bornscheuer; Stefan E Heiden; Justus U Müller; Fazal Adnan; Karsten Becker; Carlos L Correa-Martinez; Sebastian Guenther; Evgeny A Idelevich; Daniel Baecker; Katharina Schaufler
Journal:  Microbiol Spectr       Date:  2022-04-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.